SG153698A1 - Composition and method for prevention and treatment of alzheimeræs disease - Google Patents

Composition and method for prevention and treatment of alzheimeræs disease

Info

Publication number
SG153698A1
SG153698A1 SG200719013-5A SG2007190135A SG153698A1 SG 153698 A1 SG153698 A1 SG 153698A1 SG 2007190135 A SG2007190135 A SG 2007190135A SG 153698 A1 SG153698 A1 SG 153698A1
Authority
SG
Singapore
Prior art keywords
composition
disease
prevention
treatment
alzheimeræs
Prior art date
Application number
SG200719013-5A
Inventor
Pan Tzu-Ming
Lee Chun-Lin
Original Assignee
Sunway Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunway Biotech Co Ltd filed Critical Sunway Biotech Co Ltd
Priority to SG200719013-5A priority Critical patent/SG153698A1/en
Publication of SG153698A1 publication Critical patent/SG153698A1/en

Links

Abstract

COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE This invention presented is a composition and method for prevention and treatment of Alzheimer's disease, the composition comprising monacolins, anti-inflammation agents and anti- oxidant compounds is made by the method of the invention. The composition of the invention has effect on prevention and treatment of Alzheimer's disease without noticeable side effects caused to patients.
SG200719013-5A 2007-12-26 2007-12-26 Composition and method for prevention and treatment of alzheimeræs disease SG153698A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG200719013-5A SG153698A1 (en) 2007-12-26 2007-12-26 Composition and method for prevention and treatment of alzheimeræs disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200719013-5A SG153698A1 (en) 2007-12-26 2007-12-26 Composition and method for prevention and treatment of alzheimeræs disease

Publications (1)

Publication Number Publication Date
SG153698A1 true SG153698A1 (en) 2009-07-29

Family

ID=40901930

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200719013-5A SG153698A1 (en) 2007-12-26 2007-12-26 Composition and method for prevention and treatment of alzheimeræs disease

Country Status (1)

Country Link
SG (1) SG153698A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111019842A (en) * 2019-12-31 2020-04-17 光明乳业股份有限公司 Monascus purpureus and application thereof
CN111117898A (en) * 2019-12-31 2020-05-08 光明乳业股份有限公司 Monascus purpureus and application thereof
CN113424884A (en) * 2021-05-08 2021-09-24 上海共得健康科技集团有限公司 Method for preparing monascus tartary buckwheat tea by using high-temperature monascus

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02303477A (en) * 1989-05-19 1990-12-17 Oriental Foods:Kk Production of fruit vinegar
WO2006027529A2 (en) * 2004-09-03 2006-03-16 Df3 Method for obtaining fractions from bran cereals and fractions thus obtained
US20070166321A1 (en) * 2006-01-13 2007-07-19 Bryant Villeponteau Compositions and Methods for Reducing Cholesterol and Inflammation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02303477A (en) * 1989-05-19 1990-12-17 Oriental Foods:Kk Production of fruit vinegar
WO2006027529A2 (en) * 2004-09-03 2006-03-16 Df3 Method for obtaining fractions from bran cereals and fractions thus obtained
US20070166321A1 (en) * 2006-01-13 2007-07-19 Bryant Villeponteau Compositions and Methods for Reducing Cholesterol and Inflammation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RED MOLD RICE AMELIORATES IMPAIRMENT OF MEMORY AND LEARNING ABILITY IN INTRACERBROVENTRICULAR AMYLOID BETA-INFUSED RAT BY REPRESSING AMYLOID BETA ACCU *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111019842A (en) * 2019-12-31 2020-04-17 光明乳业股份有限公司 Monascus purpureus and application thereof
CN111117898A (en) * 2019-12-31 2020-05-08 光明乳业股份有限公司 Monascus purpureus and application thereof
CN113424884A (en) * 2021-05-08 2021-09-24 上海共得健康科技集团有限公司 Method for preparing monascus tartary buckwheat tea by using high-temperature monascus

Similar Documents

Publication Publication Date Title
MY145439A (en) Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
HRP20130345T1 (en) New therapeutic approaches for treating cmt and related disorders
ZA200604114B (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
MX2010004494A (en) Use of trkb antibodies for the treatment of respiratory disorders.
MX2009002920A (en) Treating pain, diabetes, and disorders of lipid metabolism.
MX2009002921A (en) Azetidinone derivatives for the treatment of disorders of the lipid metabolism.
EP2382176A4 (en) Use of nitrogen-containing curcumin analogs for the treatment alzheimer's disease
EA019970B8 (en) Imidazolidinedione derivatives
IS8505A (en) (S) -2-N-propylamino-5-hydroxyetraline as D3 agonist
UY28473A1 (en) NEW COMPOUNDS
MX2009000657A (en) Compositions and methods for the treatment of mucositis.
MX2011012015A (en) Treatment of mci and alzheimer's disease.
MX2008013196A (en) 5-amido-2-carboxamide indoles.
CY1115725T1 (en) UNIONS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF BETA-AMYLOIDIC DISEASES AND CONCLUSIONS
WO2008104385A8 (en) Method for the treatment of amyloidoses
TW200700071A (en) Novel use
MX2009005351A (en) Compounds useful for treating neurodegenerative disorders.
EA201001586A1 (en) COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
MX2009004770A (en) Carbamate compounds for use in treating depression.
PT1778837E (en) Treatment of neurodegenerative diseases by the use of scd4 inhibitors
TW200640467A (en) Compounds and uses thereof
SG153698A1 (en) Composition and method for prevention and treatment of alzheimeræs disease
MX2009013482A (en) [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases.